Cited by 1,053PI3K/AKT/mTOR signaling in cancerHippo pathway signaling and YAP/TAZMetabolism, Diabetes, and Cancer

Making new contacts: the mTOR network in metabolism and signalling crosstalk

Shimobayashi, Mitsugu, Hall, Michael N.·2014·Nature Reviews Molecular Cell Biology

Abstract

More than 20 years after its discovery, our understanding of target of rapamycin (TOR) signalling continues to grow. Recent global 'omics' studies have revealed physiological roles of mammalian TOR (mTOR) in protein, nucleotide and lipid synthesis. Furthermore, emerging evidence provides new insight into the control of mTOR by other pathways such as Hippo, WNT and Notch signalling. Together, this progress has expanded the list of downstream effectors and upstream regulators of mTOR signalling.

Integrity signals

Registry

Crossref · 10.1038/nrm3757

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Shimobayashi, M., & Hall, M. N.
Affiliations
University of Basel (CH)
Corresponding author
Hall, Michael N.
Venue
Nature Reviews Molecular Cell Biology
Published
2014-02-21
Volume
15
Issue
3
Pages
155-162
ISSN
  • 1471-0072 (ISSN-L)
  • 1471-0080
OpenAlex
W1977534471
Cited by
1,053
References
85
Citations by year
2026: 22 · 2025: 48 · 2024: 57 · 2023: 61 · 2022: 70 · 2021: 88 · 2020: 87 · 2019: 103 · 2018: 111 · 2017: 129 · 2016: 120 · 2015: 118 · 2014: 38
FWCI
12.72
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Molecular Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
mTOR signaling, TOR signaling, Hippo signaling pathway, Wnt signaling, Notch signaling, signaling crosstalk, protein synthesis, nucleotide synthesis, lipogenesis, upstream regulators, downstream effectors
MeSH terms
Animals, Antibiotics, Antineoplastic, Humans, Models, Biological, Signal Transduction, Sirolimus, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review